Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 37,222 shares at $50.02 ($1.9M) on 2021-06-09, disclosed to the SEC on 2021-06-09.
Open-market sale of $1.9M KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.14 | 12,724 | $638K | 34.2% |
| 2 | $50.14 | 12,724 | $638K | 34.2% |
| 3 | $50.00 | 270 | $14K | 0.7% |
| 4 | $50.02 | 5,752 | $288K | 15.4% |
| 5 | $50.02 | 5,752 | $288K | 15.4% |
| Total | $50.10 avg | 37,222 |
| $1.9M |
| 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2026-02-25 | $2.7M | — | Filing → |